HER2-positive breast cancer that resists therapeutic drugs and ionizing radiation releases sphingomyelin-based molecules to circulating blood serum

Breast cancer is the second most common cancer in the world based on incidence, reaching more than 2 million new cases in 2018, while continuing to increase. Invasive ductal carcinoma is the most common type of this cancer, making up approximately 70-80% of all breast cancer diagnoses. In particular...

Descripción completa

Detalles Bibliográficos
Autores principales: Monzen, Satoru, Tatara, Yota, Mariya, Yasushi, Chiba, Mitsuru, Wojcik, Andrzej, Lundholm, Lovisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523270/
https://www.ncbi.nlm.nih.gov/pubmed/33005404
http://dx.doi.org/10.3892/mco.2020.2140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7523270/
https://www.ncbi.nlm.nih.gov/pubmed/33005404
http://dx.doi.org/10.3892/mco.2020.2140

Ejemplares similares